BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27330285)

  • 1. Determinants for changing the treatment of COPD: a regression analysis from a clinical audit.
    López-Campos JL; Abad Arranz M; Calero Acuña C; Romero Valero F; Ayerbe García R; Hidalgo Molina A; Aguilar Perez-Grovas RI; García Gil F; Casas Maldonado F; Caballero Ballesteros L; Sánchez Palop M; Pérez-Tejero D; Segado A; Calvo Bonachera J; Hernández Sierra B; Doménech A; Arroyo Varela M; González Vargas F; Cruz Rueda JJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1171-8. PubMed ID: 27330285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of medical prescriptions for COPD care: an analysis of the EPOCONSUL clinical audit.
    Lopez-Campos JL; Navarrete BA; Soriano JB; Soler-Cataluña JJ; González-Moro JMR; Ferrer MEF; Rubio MC
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2279-2288. PubMed ID: 30100718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal variability in clinical care of COPD outpatients: results from the Andalusian COPD audit.
    López-Campos JL; Abad Arranz M; Calero-Acuña C; Romero-Valero F; Ayerbe-García R; Hidalgo-Molina A; Aguilar-Pérez-Grovas RI; García-Gil F; Casas-Maldonado F; Caballero-Ballesteros L; Sánchez-Palop M; Pérez-Tejero D; Segado Soriano A; Calvo-Bonachera J; Hernández-Sierra B; Doménech A; Arroyo-Varela M; González-Vargas F; Cruz-Rueda JJ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():785-792. PubMed ID: 28424549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of early medication use for COPD: a population-based cohort study.
    Falk J; Dik N; Bugden S
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3101-3108. PubMed ID: 27994449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to a COPD treatment guideline among patients in Hong Kong.
    Chan KP; Ko FW; Chan HS; Wong ML; Mok TY; Choo KL; Hui DS
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3371-3379. PubMed ID: 29238182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.
    Bathoorn E; Groenhof F; Hendrix R; van der Molen T; Sinha B; Kerstjens HA; Friedrich AW; Kocks JW
    Int J Chron Obstruct Pulmon Dis; 2017; 12():285-290. PubMed ID: 28144133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.
    Devereux G; Cotton S; Barnes P; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; De Soyza A; Fielding S; Gompertz S; Haughney J; Lee AJ; McCormack K; McPherson G; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Trials; 2015 Jun; 16():267. PubMed ID: 26058585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
    Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related.
    Koehorst-Ter Huurne K; Kort S; van der Palen J; van Beurden WJ; Movig KL; van der Valk P; Brusse-Keizer M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1679-88. PubMed ID: 27555758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: a pilot study.
    Cabrera C; Casanova C; Martín Y; Mirabal V; Sánchez Mdel C; Álvarez F; Juliá G; Cabrera-Navarro P; García-Bello MÁ; Marín JM; de-Torres JP; Divo M; Celli B
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1217-22. PubMed ID: 27354780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD.
    Yamauchi Y; Yasunaga H; Hasegawa W; Sakamoto Y; Takeshima H; Jo T; Matsui H; Fushimi K; Nagase T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1403-11. PubMed ID: 27382276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns and characterization of COPD exacerbations using real-time data collection.
    Ejiofor SI; Stolk J; Fernandez P; Stockley RA
    Int J Chron Obstruct Pulmon Dis; 2017; 12():427-434. PubMed ID: 28182151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to GOLD guideline treatment recommendations among pulmonologists in Turkey.
    Sen E; Guclu SZ; Kibar I; Ocal U; Yilmaz V; Celik O; Cimen F; Topcu F; Orhun M; Tereci H; Konya A; Ar I; Saryal S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2657-63. PubMed ID: 26715844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse relationship between nonadherence to original GOLD treatment guidelines and exacerbations of COPD.
    Foda HD; Brehm A; Goldsteen K; Edelman NH
    Int J Chron Obstruct Pulmon Dis; 2017; 12():209-214. PubMed ID: 28123293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
    Cheng SL; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2341-2348. PubMed ID: 27703344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is in the guidelines about the pharmacological treatment of chronic obstructive pulmonary disease?
    López-Campos JL; Calero Acuña C
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):43-51. PubMed ID: 23551023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COPD patients' characteristics, usual care, and adherence to guidelines: the Greek UNLOCK study.
    Tsiligianni I; Kampouraki M; Ierodiakonou D; Poulonirakis I; Papadokostakis P
    Int J Chron Obstruct Pulmon Dis; 2019; 14():547-556. PubMed ID: 30880944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD.
    Cheng SL; Wang HH; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2231-2238. PubMed ID: 28814851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cross-Sectional Study Assessing Appropriateness Of Inhaled Corticosteroid Treatment In Primary And Secondary Care Patients With COPD In Sweden.
    Sulku J; Janson C; Melhus H; Malinovschi A; Ställberg B; Bröms K; Högman M; Lisspers K; Hammarlund-Udenaes M; Nielsen EI
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2451-2460. PubMed ID: 31806954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.